“More research needs to be done, but I think this is something that gets the conversation started,” says Tony Chen, MD.
In this video, Tony Chen, MD, discusses the study, “Associations between Race and Erectile Dysfunction Treatment Patterns,” and how it contributes to the conversation of racial disparities within the health care system. This study was presented at the 2021 American Urological Association Annual Meeting. Chen is a clinical assistant professor of urology at Stanford University, California.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.